Biomarkers' performance in the SEPSIS-3 era

Amanda de la Fuente,Jaime Lopez-Sanchez,Luis Mario Vaquero-Roncero,Maria Merino Garcia,Maria Elisa Sanchez Barrado,Miguel Vicente Sanchez-Hernandez,Jesus Rico-Feijoo,Luis Munoz-Bellvis,Rafael Gonzalez de Castro,Ana P. Tedim,Alicia Ortega,Omar Abdel-lah Fernandez,Alejandro Suarez-de-la-Rica,Emilio Maseda,Ignacio Trejo Gonzalez,Geovanna Liszeth Garcia Carrera,Jose Miguel Marcos-Vidal,Juan Manuel Nieto Arranz,Carmen Esteban-Velasco,Cesar Aldecoa,Jesus F Bermejo-Martin
DOI: https://doi.org/10.1101/2023.01.18.23284703
2023-01-19
MedRxiv
Abstract:Objective: the biomarkers' performance for diagnosis and severity stratification of sepsis has not been properly evaluated anew using the SEPSIS-3 criteria introduced in 2016. We evaluated the accuracy of 21 biomarkers classically tested in sepsis research to identify infection, sepsis, and septic shock in surgical patients classified using SEPSIS-3. Methods: four groups of adult surgical patients were compared: post-surgical patients with no infection, patients with infection but no sepsis, patients with sepsis, and patients with septic shock were recruited prospectively from the surgery departments and surgical ICUs from four Spanish hospital. The area under the curve (AUC) to differentiate between groups was calculated for each biomarker. Results: A total of 187 patients were recruited (50 uninfected post-surgery controls, 50 patients with infection, 47 with sepsis and 40 with septic shock). The AUCs indicated that none of the biomarkers tested was accurate enough to differentiate those patients with infection from the uninfected controls. In contrast, procalcitonin, lipocalin 2, pentraxin 3, IL-15, TNF-, IL-6, angiopoietin 2, TREM-1, D-dimer and C-reactive protein yielded AUCs > 0.80 to discriminate the patients with sepsis or septic shock from those with no infection. C-reactive protein and IL-6 were the most accurate markers to differentiate plain infection from sepsis (AUC = 0.82). Finally, our results revealed that sepsis and septic shock shared similar profiles of biomarkers. Conclusion: Revaluation in the SEPSIS-3 era identified the scenarios where biomarkers do and do not provide useful information to improve the management of surgical patients with infection or sepsis.
What problem does this paper attempt to address?